This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lencer, R.
Right arrow Articles by Klein, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lencer, R.
Right arrow Articles by Klein, C.
The British Journal of Psychiatry (2004) 185: 465-471
© 2004 The Royal College of Psychiatrists

Family history of primary movement disorders as a predictor for neuroleptic-induced extrapyramidal symptoms

Rebekka Lencer, MD and Gunnar Eismann, BSc

Department of Psychiatry and Psychotherapy; University of Lübeck, Germany

Meike Kasten, MD and Kemal Kabakci, MD

Department of Neurology; University of Lübeck, Germany

Verena Geithe, MD and Jenny Grimm, MD

Department of Psychiatry and Psychotherapy; University of Lübeck, Germany

Christine Klein, MD

Department of Neurology, University of Lübeck, Germany

Correspondence: Dr Reb Rebekka ekka Lencer, Klinik für Psychiatrie und Psychotherapie, Universitä zu Lübeck, Ratzeburger Allee 160, 23538 Lü, Germany. Tel: +49 451 500 2444; fax: +49 451 500 4957; e-mail: lencer.r{at}psychiatry.uni-luebeck.de

Declaration of interest None.

Funding detailed in Acknowledgements.

Background Agenetic susceptibility to extrapyramidal symptoms caused by treatment with neuroleptic medication has been suggested.

Aims To identify predictor variables for neuroleptic-induced extrapyramidal symptoms, particularly considering family history of primary movement disorders.

Method We investigated 100 in-patients receiving a stable neuroleptic medication with regard to occurrence of extrapyramidal symptoms, drug history and detailed family history of primary movement disorders.

Results Step-wise logistic regression analysis revealed that a positive family history was a significant predictor for lifetime prevalence of extrapyramidal symptoms, including reported and currently observed symptoms. The duration of exposure to neuroleptic medication and age were further predictors.

Conclusions Our findings underline the notion of genetic susceptibility for secondary extrapyramidal symptoms and suggest possible shared genetic factors in primary and secondary movement disorders as well as psychotic disorders.




This article has been cited by other articles:


Home page
 Adv. Psychiatr. Treat.Home page
M. M. Picchioni and P. Dazzan
Clinical significance of neurological abnormalities in psychosis
Adv. Psychiatr. Treat., November 1, 2009; 15(6): 419 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Schizophr BullHome page
J. P. Koning, D. E Tenback, J. van Os, A. Aleman, R. S. Kahn, and P. N. van Harten
Dyskinesia and Parkinsonism in Antipsychotic-Naive Patients With Schizophrenia, First-Degree Relatives and Healthy Controls: A Meta-analysis
Schizophr Bull, November 5, 2008; (2008) sbn146v1.
[Abstract] [Full Text] [PDF]